These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10623754)

  • 41. Mucosal immunity induced by parenteral immunization with a live attenuated Venezuelan equine encephalitis virus vaccine candidate.
    Charles PC; Brown KW; Davis NL; Hart MK; Johnston RE
    Virology; 1997 Feb; 228(2):153-60. PubMed ID: 9123821
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.
    Johnson BJ; Brubaker JR; Roehrig JT; Trent DW
    Virology; 1990 Aug; 177(2):676-83. PubMed ID: 1695412
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Venezuelan equine encephalitis virus in the mosquito vector Aedes taeniorhynchus: infection initiated by a small number of susceptible epithelial cells and a population bottleneck.
    Smith DR; Adams AP; Kenney JL; Wang E; Weaver SC
    Virology; 2008 Mar; 372(1):176-86. PubMed ID: 18023837
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus].
    Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV
    Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Laminin-binding protein (LBP) as a cellular receptor for the virus of Venezuelan equine encephalomyelitis (VEE): Part 1. A study of the interaction between VEE virus virions and the human recombinant LBP].
    Bondarenko EI; Protopopova EV; Konovalova SN; Sorokin AV; Kachko AV; Surovtsev IV; Loktev VB
    Mol Gen Mikrobiol Virusol; 2003; (4):36-9. PubMed ID: 14664162
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An alphavirus replicon particle chimera derived from venezuelan equine encephalitis and sindbis viruses is a potent gene-based vaccine delivery vector.
    Perri S; Greer CE; Thudium K; Doe B; Legg H; Liu H; Romero RE; Tang Z; Bin Q; Dubensky TW; Vajdy M; Otten GR; Polo JM
    J Virol; 2003 Oct; 77(19):10394-403. PubMed ID: 12970424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Equine amplification and virulence of subtype IE Venezuelan equine encephalitis viruses isolated during the 1993 and 1996 Mexican epizootics.
    Gonzalez-Salazar D; Estrada-Franco JG; Carrara AS; Aronson JF; Weaver SC
    Emerg Infect Dis; 2003 Feb; 9(2):161-8. PubMed ID: 12603985
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Tonate virus (subtype IIIB of the Venezuelan equine encephalitis complex) with encephalitis in a human.
    Hommel D; Heraud JM; Hulin A; Talarmin A
    Clin Infect Dis; 2000 Jan; 30(1):188-90. PubMed ID: 10619752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mutations in the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice.
    Bernard KA; Klimstra WB; Johnston RE
    Virology; 2000 Oct; 276(1):93-103. PubMed ID: 11021998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Venezuelan equine encephalitis replicon particles packaged in different coats.
    Kamrud KI; Alterson KD; Andrews C; Copp LO; Lewis WC; Hubby B; Patel D; Rayner JO; Talarico T; Smith JF
    PLoS One; 2008 Jul; 3(7):e2709. PubMed ID: 18628938
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone.
    Davis NL; Powell N; Greenwald GF; Willis LV; Johnson BJ; Smith JF; Johnston RE
    Virology; 1991 Jul; 183(1):20-31. PubMed ID: 2053280
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Venezuelan equine encephalitis virus vaccine candidate (V3526) safety, immunogenicity and efficacy in horses.
    Fine DL; Roberts BA; Teehee ML; Terpening SJ; Kelly CL; Raetz JL; Baker DC; Powers AM; Bowen RA
    Vaccine; 2007 Feb; 25(10):1868-76. PubMed ID: 17240002
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles.
    Harrington PR; Yount B; Johnston RE; Davis N; Moe C; Baric RS
    J Virol; 2002 Jan; 76(2):730-42. PubMed ID: 11752163
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Venezuelan equine encephalitis virus in the guinea pig model: evidence for epizootic virulence determinants outside the E2 envelope glycoprotein gene.
    Greene IP; Paessler S; Anishchenko M; Smith DR; Brault AC; Frolov I; Weaver SC
    Am J Trop Med Hyg; 2005 Mar; 72(3):330-8. PubMed ID: 15772331
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Virulent and attenuated mutant Venezuelan equine encephalitis virus show marked differences in replication in infection in murine macrophages.
    Grieder FB; Nguyen HT
    Microb Pathog; 1996 Aug; 21(2):85-95. PubMed ID: 8844652
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The course of airborne infection in rabbits infected with the Venezuelan encephalomyelitis virus].
    Sergeev AN; Ryzhikov AB; Bulychev LE; Stepkina EO; Tkacheva NV
    Vopr Virusol; 1991; 36(6):492-5. PubMed ID: 1785185
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Infections of congenitally athymic (nude) and normal mice with avirulent and virulent strains of Venezuelan encephalitis virus.
    LeBlanc PA; Scherer WF; Sussdorf DH
    Infect Immun; 1978 Sep; 21(3):779-85. PubMed ID: 711332
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of angiotensin II in experimental Venezuelan equine encephalitis in rats.
    Bermúdez J; Valero N; Mosquera J; Vargas R; Hernández-Fonseca JP; Quiroz Y; Godoy R
    Arch Virol; 2015 Oct; 160(10):2395-405. PubMed ID: 26156105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficient packaging of Venezuelan equine encephalitis virus-specific RNAs into viral particles is determined by nsP1-3 synthesis.
    Volkova E; Gorchakov R; Frolov I
    Virology; 2006 Jan; 344(2):315-27. PubMed ID: 16239019
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Inhibition of replication of Venezuelan equine encephalomyelitis with polyclonal antibodies to laminin-binding protein].
    Bondarenko EI; Protopopova EV; Surovtsev IV; Shvalov AN; Loktev VB
    Vopr Virusol; 2004; 49(5):32-7. PubMed ID: 15529862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.